Published May 9, 2023 | Version public
Journal Article

Poly‐Catecholic Functionalization of Biomolecules for Rapid Gelation, Robust Injectable Bioadhesion, and Near‐Infrared Responsiveness

  • 1. ROR icon University of California, Los Angeles
  • 2. ROR icon California NanoSystems Institute
  • 3. ROR icon Terasaki Foundation
  • 4. ROR icon California Institute of Technology

Abstract

Mussel-inspired catechol-functionalization of degradable natural biomaterials has garnered significant interest as an approach to achieve bioadhesion for sutureless wound closure. However, conjugation capacity in standard coupling reactions, such as carbodiimide chemistry, is limited by low yield and lack of abundant conjugation sites. Here, a simple oxidative polymerization step before conjugation of catechol-carrying molecules (i.e., 3,4-dihydroxy-l-phenylalanine, l-DOPA) as a potential approach to amplify catechol function in bioadhesion of natural gelatin biomaterials is proposed. Solutions of gelatin modified with poly(l-DOPA) moieties (GelDOPA) are characterized by faster physical gelation and increased viscosity, providing better wound control on double-curved tissue surfaces compared to those of l-DOPA-conjugated gelatin. Physical hydrogels treated topically with low concentrations of NaIO4 solutions are crosslinked on-demand via through-thickness diffusion. Poly(l-DOPA) conjugates enhance crosslinking density compared to l-DOPA conjugated gelatin, resulting in lower swelling and enhanced cohesion in physiological conditions. Together with cohesion, more robust bioadhesion at body temperature is achieved by poly(l-DOPA) conjugates, exceeding those of commercial sealants. Further, poly(l-DOPA) motifs introduced photothermal responsiveness via near-infrared (NIR) irradiation for controlled drug release and potential applications in photothermal therapy. The above functionalities, along with antibacterial activity, render the proposed approach an effective biomaterial design strategy for wound closure applications.

Additional Information

© 2023 Wiley-VCH. The authors acknowledge the financial support from the National Institutes of Health (1R01EB023052-01A1, 1R01HL140618-01, 1R01AR073135-01A1, and T32EB023858) and the Terasaki Institute of Biomedical Innovation. E.D. thanks the support from the National Institutes of Health (T32EB023858). The authors thank Ms. Judy Cheng for TEM imaging and Dr. Reza Abbasgholizadeh for preparing tissue slides from animal studies. The authors thank Ms. Katie White for her helpful discussions and scientific comments. Author Contributions. The research idea and experimental design were developed and the majority of experiments were conducted by H.M. A.H.N. performed animal studies. Characterization and analyses of NIR responsiveness were implemented by E.D. R.S. executed in vitro biocompatibility studies. The 1H NMR characterization and antibacterial assessments were performed by A.B. and R.H., respectively. H.M. prepared the original draft of the manuscript. W.G., N.A., A.K., and P.S.W. conceived of this study, supervised, and contributed to the writing of the manuscript. The final version of the manuscript has been approved by all authors. Data Availability Statement. The data that support the findings of this study are available in the supplementary material of this article. The authors declare no conflict of interest.

Additional details

Identifiers

Eprint ID
120700
Resolver ID
CaltechAUTHORS:20230404-448520900.8

Funding

NIH
1R01EB023052‐01A1
NIH
1R01HL140618‐01
NIH
1R01AR073135‐01A1
NIH Predoctoral Fellowship
T32EB023858
Terasaki Institute of Biomedical Innovation

Dates

Created
2023-05-09
Created from EPrint's datestamp field
Updated
2023-05-09
Created from EPrint's last_modified field